Insider · CIK 0001950802
Elizabeth Forminard
Files at JNJ (JOHNSON & JOHNSON). First filing Aug 7, 2026, latest Aug 7, 2026.
In brief
Elizabeth Forminard files SEC Form 4 as officer at JNJ (JOHNSON & JOHNSON). Since Aug 7, 2026, Elizabeth Forminard has reported 0 open-market buys worth $0 and 1 open-market sell worth $4.1M, the latest filed on Aug 7, 2026.
A track record needs three past buys with six months of prices behind them; Elizabeth Forminard has 0, so none is measured yet.
The newest scored trade: sold $4.1M of JNJ on Aug 6, 2026, filed Aug 7, 2026, scored 50 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $4.1M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JNJ: JOHNSON & JOHNSON
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | JOHNSON & JOHNSON | $4.1M 15,918 shares | -48% | +54% from low-4% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 6, 2026 | JNJ JOHNSON & JOHNSON | 15,918 0.00% of outstanding | $4.1M | Aug 6, 2026 | none |
| Feb 5, 2026 | JNJ JOHNSON & JOHNSON | 6,226 0.00% of outstanding | $1.5M | Feb 5, 2026 | none |
| Aug 29, 2025 | JNJ JOHNSON & JOHNSON | 9,570 0.00% of outstanding | $1.7M | Aug 29, 2025 | none |
Transactions
The newest 50 of 52 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +9,344 | $131.94 | $1.2M | 32,912 | Aug 7, 2026 |
| Aug 6, 2026 | JNJ JOHNSON & JOHNSON | SOpen-market sale Common Stock | -9,344 | $257.76 | $2.4M | 23,568 | Aug 7, 2026 |
| Aug 6, 2026 | JNJ JOHNSON & JOHNSON | SOpen-market sale Common Stock | -6,574 | $255.93 | $1.7M | 16,994 | Aug 7, 2026 |
| Aug 6, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Employee Stock Options (Right to Buy)derivative | -9,344 | $0.00 | $0 | 0 | Aug 7, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +651 | $0.00 | $0 | 16,199 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -314 | $244.55 | $77k | 15,885 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +13,706 | $0.00 | $0 | 29,591 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -7,011 | $244.55 | $1.7M | 22,580 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +961 | $0.00 | $0 | 23,541 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -492 | $243.45 | $120k | 23,049 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +1,063 | $0.00 | $0 | 24,112 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -544 | $243.45 | $132k | 23,568 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -651 | $0.00 | $0 | 0 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Performance Share Unitsderivative | -13,706 | $0.00 | $0 | 0 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -961 | $0.00 | $0 | 961 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -1,063 | $0.00 | $0 | 2,126 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | AGrant or award Employee Stock Options (Right to Buy)derivative | +27,076 | $0.00 | $0 | 27,076 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | AGrant or award Restricted Share Unitsderivative | +1,944 | $0.00 | $0 | 1,944 | Feb 18, 2026 |
| Feb 9, 2026 | JNJ JOHNSON & JOHNSON | AGrant or award Performance Share Unitsderivative | +13,706 | $0.00 | $0 | 13,706 | Feb 11, 2026 |
| Feb 5, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +8,921 | $129.51 | $1.2M | 21,774 | Feb 6, 2026 |
| Feb 5, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -6,226 | $237.90 | $1.5M | 15,548 | Feb 6, 2026 |
| Feb 5, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Employee Stock Options (Right to Buy)derivative | -8,921 | $129.51 | $1.2M | 0 | Feb 6, 2026 |
| Aug 29, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +11,521 | $115.67 | $1.3M | 22,423 | Sep 3, 2025 |
| Aug 29, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -9,570 | $177.20 | $1.7M | 12,853 | Sep 3, 2025 |
| Aug 29, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Employee Stock Options (Right to Buy)derivative | -11,521 | $115.67 | $1.3M | 0 | Sep 3, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | AGrant or award Employee Stock Options (Right to Buy)derivative | +51,688 | $0.00 | $0 | 51,688 | Feb 19, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | AGrant or award Restricted Share Unitsderivative | +3,189 | $0.00 | $0 | 3,189 | Feb 19, 2025 |
| Feb 13, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +651 | $0.00 | $0 | 8,991 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -215 | $155.26 | $33k | 8,776 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +851 | $0.00 | $0 | 9,627 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -267 | $156.71 | $42k | 9,360 | Feb 18, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +961 | $0.00 | $0 | 10,321 | Feb 18, 2025 |
| Feb 18, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -307 | $156.15 | $48k | 10,014 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +1,352 | $0.00 | $0 | 11,366 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -464 | $156.71 | $73k | 10,902 | Feb 18, 2025 |
| Feb 13, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -651 | $0.00 | $0 | 651 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -851 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -961 | $0.00 | $0 | 1,922 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Performance Share Unitsderivative | -1,352 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 10, 2025 | JNJ JOHNSON & JOHNSON | AGrant or award Performance Share Unitsderivative | +1,352 | $0.00 | $0 | 1,352 | Feb 12, 2025 |
| Feb 15, 2024 | JNJ JOHNSON & JOHNSON | AGrant or award Employee Stock Options (Right to Buy)derivative | +46,406 | $0.00 | $0 | 46,406 | Feb 20, 2024 |
| Feb 15, 2024 | JNJ JOHNSON & JOHNSON | AGrant or award Restricted Share Unitsderivative | +2,883 | $0.00 | $0 | 2,883 | Feb 20, 2024 |
| Feb 13, 2024 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +651 | $0.00 | $0 | 8,576 | Feb 15, 2024 |
| Feb 13, 2024 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -236 | $157.85 | $37k | 8,340 | Feb 15, 2024 |
| Feb 13, 2024 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -651 | $0.00 | $0 | 1,302 | Feb 15, 2024 |
| Feb 12, 2024 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +2,448 | $0.00 | $0 | 8,548 | Feb 14, 2024 |
| Feb 12, 2024 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +411 | $0.00 | $0 | 8,959 | Feb 14, 2024 |
| Feb 12, 2024 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -1,034 | $157.40 | $163k | 7,925 | Feb 14, 2024 |
| Feb 12, 2024 | JNJ JOHNSON & JOHNSON | MOption exercise Performance Share Unitsderivative | -2,448 | $0.00 | $0 | 0 | Feb 14, 2024 |
| Feb 8, 2024 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +979 | $0.00 | $0 | 6,463 | Feb 12, 2024 |
Questions about Elizabeth Forminard
Answered from the filings on this page, as of the latest one.
Is Elizabeth Forminard buying or selling?
In the last 12 months Elizabeth Forminard reported 0 open-market buys worth $0 and 1 open-market sell worth $4.1M on SEC Form 4; the latest was sold $4.1M of JNJ on Aug 6, 2026. Grants, option exercises and tax withholding are not counted.
How did Elizabeth Forminard's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elizabeth Forminard has 0.
Where does Elizabeth Forminard file Form 4?
Elizabeth Forminard has filed Form 4 at JNJ (JOHNSON & JOHNSON) as Executive VP, General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.